The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 1447 | 2015 |
Punctuated evolution of prostate cancer genomes SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ... Cell 153 (3), 666-677, 2013 | 1004 | 2013 |
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ... Nature medicine 22 (3), 298-305, 2016 | 788 | 2016 |
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer P Mu, Z Zhang, M Benelli, WR Karthaus, E Hoover, CC Chen, ... Science 355 (6320), 84-88, 2017 | 468 | 2017 |
Personalized in vitro and in vivo cancer models to guide precision medicine C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Cancer discovery 7 (5), 462-477, 2017 | 419 | 2017 |
Tumor clone dynamics in lethal prostate cancer S Carreira, A Romanel, J Goodall, E Grist, R Ferraldeschi, S Miranda, ... Science translational medicine 6 (254), 254ra125-254ra125, 2014 | 305 | 2014 |
Genomic correlates of clinical outcome in advanced prostate cancer W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ... Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019 | 262 | 2019 |
Whole-exome sequencing of metastatic cancer and biomarkers of treatment response H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ... JAMA oncology 1 (4), 466-474, 2015 | 227 | 2015 |
A highly specific SpCas9 variant is identified by in vivo screening in yeast A Casini, M Olivieri, G Petris, C Montagna, G Reginato, G Maule, ... Nature biotechnology 36 (3), 265, 2018 | 207 | 2018 |
Clonal evolution of chemotherapy-resistant urothelial carcinoma BM Faltas, D Prandi, ST Tagawa, AM Molina, DM Nanus, C Sternberg, ... Nature genetics 48 (12), 1490, 2016 | 167 | 2016 |
GPU computing for systems biology L Dematté, D Prandi Briefings in bioinformatics 11 (3), 323-333, 2010 | 149 | 2010 |
SPOP mutation leads to genomic instability in prostate cancer G Boysen, CE Barbieri, D Prandi, M Blattner, SS Chae, A Dahija, ... Elife 4, e09207, 2015 | 110 | 2015 |
Patient derived organoids to model rare prostate cancer phenotypes L Puca, R Bareja, D Prandi, R Shaw, M Benelli, WR Karthaus, J Hess, ... Nature communications 9 (1), 1-10, 2018 | 106 | 2018 |
Unraveling the clonal hierarchy of somatic genomic aberrations D Prandi, SC Baca, A Romanel, CE Barbieri, JM Mosquera, J Fontugne, ... Genome biology 15 (8), 1-16, 2014 | 81 | 2014 |
Beta-binders for biological quantitative experiments P Degano, D Prandi, C Priami, P Quaglia Electronic Notes in Theoretical Computer Science 164 (3), 101-117, 2006 | 79 | 2006 |
A phase II trial of the aurora kinase a inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer: efficacy and biomarkers H Beltran, C Oromendia, DC Danila, B Montgomery, C Hoimes, ... Clinical cancer research 25 (1), 43-51, 2019 | 76 | 2019 |
Formal analysis of BPMN via a translation into COWS D Prandi, P Quaglia, N Zannone International Conference on Coordination Languages and Models, 249-263, 2008 | 65 | 2008 |
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit G Petris, A Casini, C Montagna, F Lorenzin, D Prandi, A Romanel, ... Nature communications 8 (1), 1-9, 2017 | 63 | 2017 |
ASEQ: fast allele-specific studies from next-generation sequencing data A Romanel, S Lago, D Prandi, A Sboner, F Demichelis BMC medical genomics 8 (1), 1-12, 2015 | 53 | 2015 |
Stochastic cows D Prandi, P Quaglia International Conference on Service-Oriented Computing, 245-256, 2007 | 52 | 2007 |